Head-To-Head Survey: Spree Acquisition Corp. 1 (NYSE:SHAP) and Accolade (NASDAQ:ACCD)

Spree Acquisition Corp. 1 (NYSE:SHAP) and Accolade (NASDAQ:ACCD) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, profitability and risk.

Volatility & Risk

Spree Acquisition Corp. 1 has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Accolade has a beta of 2.1, indicating that its stock price is 110% more volatile than the S&P 500.

Insider & Institutional Ownership

9.9% of Spree Acquisition Corp. 1 shares are held by institutional investors. Comparatively, 85.0% of Accolade shares are held by institutional investors. 58.4% of Spree Acquisition Corp. 1 shares are held by insiders. Comparatively, 8.2% of Accolade shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Spree Acquisition Corp. 1 and Accolade’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spree Acquisition Corp. 1	N/A	-22.17%	6.72%
Accolade	-40.36%	-20.74%	-11.33%

Earnings & Valuation

This table compares Spree Acquisition Corp. 1 and Accolade”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spree Acquisition Corp. 1	N/A	N/A	$4.35 million	N/A	N/A
Accolade	$446.72 million	1.29	-$99.81 million	($2.25)	-3.12

Spree Acquisition Corp. 1 has higher earnings, but lower revenue than Accolade.

Analyst Recommendations

This is a breakdown of recent ratings for Spree Acquisition Corp. 1 and Accolade, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spree Acquisition Corp. 1	0	0	0	0	0.00
Accolade	0	13	1	0	2.07

Accolade has a consensus target price of $6.51, indicating a potential downside of 7.31%. Given Accolade’s stronger consensus rating and higher possible upside, analysts plainly believe Accolade is more favorable than Spree Acquisition Corp. 1.

Summary

Accolade beats Spree Acquisition Corp. 1 on 7 of the 11 factors compared between the two stocks.

About Spree Acquisition Corp. 1

Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia.

About Accolade

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.